Type I Interferon in Children with Viral or Bacterial Infections - Archive ouverte HAL Access content directly
Journal Articles Clinical Chemistry Year : 2020

Type I Interferon in Children with Viral or Bacterial Infections

(1, 2) , (2, 3) , (4) , (1) , (5) , (6, 7) , (7) , (2, 3) , (1) , (1) , (4, 8) , (4, 8)
1
2
3
4
5
6
7
8
Lucille Boisselier
  • Function : Author
Sylvie Pons
  • Function : Author
Karen Brengel-Pesce

Abstract

Background: Fever is one of the leading causes of consultation in the pediatric emergency department for patients under the age of 3 years. Distinguishing between bacterial and viral infections etiologies in febrile patients remains challenging. We hypothesized that specific host biomarkers for viral infections, such as type I-interferon (IFN), could help clinicians' decisions and limit antibiotic overuse. Methods: Paxgene tubes and serum were collected from febrile children (n = 101), age from 7 days to 36 months, with proven viral or bacterial infections, being treated at pediatric emergency departments in France. We assessed the performance of an IFN signature, which was based on quantification of expression of IFN-stimulated genes using the Nanostring® technology and plasma IFN-α quantified by digital ELISA technology. Results: Serum concentrations of IFN-α were below the quantification threshold (30 fg/mL) for 2% (1/46) of children with proven viral infections and for 71% (39/55) of children with bacterial infections (P < 0.001). IFN-α concentrations and IFN score were significantly higher in viral compared to bacterial infection (P < 0.001). There was a strong correlation between serum IFN-α concentrations and IFN score (p-pearson = 0.83). Both serum IFN-α concentration and IFN score robustly discriminated (Area Under the Curve >0.91 for both) between viral and bacterial infection in febrile children, compared to C-reactive protein (0.83). Conclusions: IFN-α is increased in blood of febrile infants with viral infections. The discriminative performance of IFN-α femtomolar concentrations as well as blood transcriptional signatures could show a diagnostic benefit and potentially limit antibiotic overuse.
Fichier principal
Vignette du fichier
CLINCHEM-2020-317636_R1.pdf (1.36 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02935745 , version 1 (10-09-2020)

Identifiers

Cite

Sophie Trouillet-Assant, Sébastien Viel, Antoine Ouziel, Lucille Boisselier, Philippe Rebaud, et al.. Type I Interferon in Children with Viral or Bacterial Infections. Clinical Chemistry, 2020, 66 (6), pp.802-808. ⟨10.1093/clinchem/hvaa089⟩. ⟨inserm-02935745⟩
86 View
36 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More